Dr. Allen Taylor, an ARBITER-6 HALT trial investigator, should probably avoid talking to Merck investors for the next few weeks lest he get punched in the nose. It was Allen and his colleagues' ...

Your doctor may recommend Zetia for kinds of high cholesterol. It’s a brand-name prescription drug that can be used in adults and some children. Specifically, Zetia can be used with a low cholesterol ...

The evidence says Merck's cholesterol-lowering drug Zetia should be a niche product. It works by a little-understood mode of action. No trials show that it prevents heart attacks. Yet Merck's clever ...

Add Yahoo as a preferred source to see more of our stories on Google. By Bill Berkrot CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol ...

Merck & Co.'s big-selling cholesterol-fighter Zetia is at the end of its exclusive road. The $2.5 billion seller now faces its first generic competitor, which threatens not only its own revenue, but ...

Nov 10 (Reuters) - Merck & Co on Monday said long-awaited data from an 18,000-patient trial suggest the company will not have to write down the value of its blockbuster Zetia and Vytorin cholesterol ...

Despite new US cholesterol guidelines and a clinical trial that tamped down hopes that Merck’s cholesterol drug Zetia could make a difference in the rare disease space, an analysis of prescription ...

Merck and Schering-Plough have received approval from the Food and Drug Administration to market Zetia, a new cholesterol drug. It is expected to be a blockbuster, although analysts differ on exactly ...

A small head-to-head study of two drugs that fight cholesterol is creating a big buzz at a meeting of heart specialists. Patients who took Merck's Zetia, a medicine which blocks cholesterol uptake ...

After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients when used with an ...